MedTrace Logo

Screening DIVA - Diffuse Vascular Disease

NCT01076738 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2233

Last updated 2010-09-13

No results posted yet for this study

Summary

Primary Objective:

To investigate the value of the Edinburgh Claudication Questionnaire (ECQ) against the ankle-brachial index (ABI) in Canadian patients mainly followed in general practice, with documented acute coronary syndrome (ACS)/ischemic stroke (IS)/transient ischemic attack (TIA) and who are not known to have peripheral arterial disease (PAD) at the time of enrolment.

Secondary Objective:

To collect data on the prevalence of PAD in this population as measured by ABI.

Conditions

  • Peripheral Vascular Diseases

Sponsors & Collaborators

Principal Investigators

  • Medical Affairs · Sanofi

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01076738 on ClinicalTrials.gov